VERLYX PHARMA INC has a total of 13 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2013. It filed its patents most often in United States, EPO (European Patent Office) and Mexico. Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are MEDISYN TECHNOLOGIES INC, OLATEC THERAPEUTICS LLC and RESOLVYX PHARMACEUTICALS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 3 | |
#2 | EPO (European Patent Office) | 2 | |
#3 | Mexico | 2 | |
#4 | Australia | 1 | |
#5 | Brazil | 1 | |
#6 | Canada | 1 | |
#7 | China | 1 | |
#8 | Hong Kong | 1 | |
#9 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Acyclic or carbocyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Colin Patrick | 6 |
#2 | Falardeau Pierre | 6 |
#3 | Ravenelle François | 6 |
#4 | Therien Michel | 5 |
#5 | Zaghdane Helmi | 5 |
#6 | Ravenelle Francois | 4 |
#7 | François Ravenelle | 2 |
#8 | Michel Therien | 1 |
#9 | Helmi Zaghdane | 1 |
#10 | Pierre Falardeau | 1 |
Publication | Filing date | Title |
---|---|---|
EP3558938A1 | Amidine substituted analogues and uses thereof | |
AU2013362755A1 | Uses and methods for the treatment of liver diseases or conditions |